We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$3.25B
Cap. Flow
+$3.84B
Cap. Flow %
24.9%
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$246M
2
MSFT icon
Microsoft
MSFT
+$216M
3
AMZN icon
Amazon
AMZN
+$130M
4
TSLA icon
Tesla
TSLA
+$79.6M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$73.3M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 12.21%
3 Financials 12.1%
4 Consumer Discretionary 11.41%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOR icon
2776
Vor Biopharma
VOR
$1.21B
-413
Closed -$96.1K
ONIT
2777
Onity Group
ONIT
$321M
-2,895
Closed -$116K
GRTS
2778
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-15,799
Closed -$203K
ASXC
2779
DELISTED
Asensus Surgical, Inc.
ASXC
-92,945
Closed -$103K
FUV
2780
DELISTED
Arcimoto, Inc. Common Stock
FUV
-69
Closed -$10.8K
NGMS
2781
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
-4,756
Closed -$132K
VIEW
2782
DELISTED
View, Inc. Class A Common Stock
VIEW
-931
Closed -$218K
AMTI
2783
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-8,573
Closed -$120K
TRHC
2784
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-9,238
Closed -$139K
SPPI
2785
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-8,517
Closed -$10.8K
JNCE
2786
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-1,671
Closed -$14K
VLDR
2787
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-32,008
Closed -$149K
CLVS
2788
DELISTED
Clovis Oncology, Inc.
CLVS
-43,789
Closed -$119K
RMO
2789
DELISTED
Romeo Power, Inc.
RMO
-48,590
Closed -$177K
EPZM
2790
DELISTED
Epizyme, Inc
EPZM
-6,462
Closed -$16.2K
APR
2791
DELISTED
Apria, Inc. Common Stock
APR
-7,802
Closed -$254K
CONE
2792
DELISTED
CyrusOne Inc Common Stock
CONE
-61,503
Closed -$5.52M
FRTA
2793
DELISTED
Forterra, Inc
FRTA
-11,105
Closed -$264K
KRA
2794
DELISTED
Kraton Corporation
KRA
-10,374
Closed -$481K
ARNA
2795
DELISTED
Arena Pharmaceuticals Inc
ARNA
-21,270
Closed -$1.98M
CPLG
2796
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
-13,689
Closed -$215K
ACBI
2797
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
-6,376
Closed -$183K
INFO
2798
DELISTED
IHS Markit Ltd. Common Shares
INFO
-88,119
Closed -$11.7M
RRD
2799
DELISTED
RR Donnelley & Sons Co.
RRD
-24,741
Closed -$279K
VCRA
2800
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
-11,635
Closed -$754K

Similar funds

MetLife Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.

  • MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
  • MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
  • MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
  • MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
  • MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
  • MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.